Cargando…

Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans

OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). METHODS: The E-coach chronic disease management model was constructed based on a literature review and expert intervi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, You-Yuan, Cao, Wen-Dong, Zhang, Xiao-Hong, Du, Rong-Xin, Wang, Xue-Qi, Li, Jing, Chen, Juan, Yang, Jun-Zi, Chen, Jia-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612356/
https://www.ncbi.nlm.nih.gov/pubmed/37891631
http://dx.doi.org/10.1186/s41043-023-00454-7
_version_ 1785128686445395968
author Yuan, You-Yuan
Cao, Wen-Dong
Zhang, Xiao-Hong
Du, Rong-Xin
Wang, Xue-Qi
Li, Jing
Chen, Juan
Yang, Jun-Zi
Chen, Jia-Qi
author_facet Yuan, You-Yuan
Cao, Wen-Dong
Zhang, Xiao-Hong
Du, Rong-Xin
Wang, Xue-Qi
Li, Jing
Chen, Juan
Yang, Jun-Zi
Chen, Jia-Qi
author_sort Yuan, You-Yuan
collection PubMed
description OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). METHODS: The E-coach chronic disease management model was constructed based on a literature review and expert interviews. The effect of the E-coach model on patients with ASO during hospitalisation was analysed by comparing the compliance rates of blood glucose control, blood pressure control, drug compliance, ankle-brachial index, 6-min walking test (6MWT) and pain-free walking distance (PFWD) scores between the E-coach and control groups. RESULTS: In total, 212 patients with ASO were included in this study. After the intervention, the blood pressure compliance rate (44.8% vs. 65.7%) and blood glucose compliance rate (48.6% vs. 66.8%) were higher in the E-coach group than in the control group (p < 0.05). After intervention, compared with the control group, the patients in the E-coach group had better drug compliance (6.8 ± 1.9 vs. 7.9 ± 1.0), and the difference was statistically significant (p < 0.05). The scores for the 6MWT (329.19 ± 5.58 vs. 353.00 ± 9.76; 412.65 ± 12.59 vs. 499.16 ± 18.43) and PFWD (219.15 ± 11.96 vs. 225.36 ± 16.13; 331.62 ± 51.36 vs. 369.42 ± 75.71) tests were significantly higher in the E-coach group than in the control group at 1 and 6 months after intervention (p < 0.05). CONCLUSION: The E-coach chronic disease management model can effectively improve the control rates of blood glucose and blood pressure and the behaviour management of patients with ASO and is thus worthy of clinical reference.
format Online
Article
Text
id pubmed-10612356
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106123562023-10-29 Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans Yuan, You-Yuan Cao, Wen-Dong Zhang, Xiao-Hong Du, Rong-Xin Wang, Xue-Qi Li, Jing Chen, Juan Yang, Jun-Zi Chen, Jia-Qi J Health Popul Nutr Research OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). METHODS: The E-coach chronic disease management model was constructed based on a literature review and expert interviews. The effect of the E-coach model on patients with ASO during hospitalisation was analysed by comparing the compliance rates of blood glucose control, blood pressure control, drug compliance, ankle-brachial index, 6-min walking test (6MWT) and pain-free walking distance (PFWD) scores between the E-coach and control groups. RESULTS: In total, 212 patients with ASO were included in this study. After the intervention, the blood pressure compliance rate (44.8% vs. 65.7%) and blood glucose compliance rate (48.6% vs. 66.8%) were higher in the E-coach group than in the control group (p < 0.05). After intervention, compared with the control group, the patients in the E-coach group had better drug compliance (6.8 ± 1.9 vs. 7.9 ± 1.0), and the difference was statistically significant (p < 0.05). The scores for the 6MWT (329.19 ± 5.58 vs. 353.00 ± 9.76; 412.65 ± 12.59 vs. 499.16 ± 18.43) and PFWD (219.15 ± 11.96 vs. 225.36 ± 16.13; 331.62 ± 51.36 vs. 369.42 ± 75.71) tests were significantly higher in the E-coach group than in the control group at 1 and 6 months after intervention (p < 0.05). CONCLUSION: The E-coach chronic disease management model can effectively improve the control rates of blood glucose and blood pressure and the behaviour management of patients with ASO and is thus worthy of clinical reference. BioMed Central 2023-10-27 /pmc/articles/PMC10612356/ /pubmed/37891631 http://dx.doi.org/10.1186/s41043-023-00454-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yuan, You-Yuan
Cao, Wen-Dong
Zhang, Xiao-Hong
Du, Rong-Xin
Wang, Xue-Qi
Li, Jing
Chen, Juan
Yang, Jun-Zi
Chen, Jia-Qi
Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
title Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
title_full Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
title_fullStr Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
title_full_unstemmed Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
title_short Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
title_sort application of e-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612356/
https://www.ncbi.nlm.nih.gov/pubmed/37891631
http://dx.doi.org/10.1186/s41043-023-00454-7
work_keys_str_mv AT yuanyouyuan applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT caowendong applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT zhangxiaohong applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT durongxin applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT wangxueqi applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT lijing applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT chenjuan applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT yangjunzi applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans
AT chenjiaqi applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans